OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.
The idea of building AI agents sounds great; however, the reality can be very difficult. If you're one of the many people who have tried building AI agents, then you probably already know that there ...